These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8188080)

  • 1. Interphase AgNOR quantity and DNA content in endometrial adenocarcinoma.
    Trerè D; Melchiorri C; Chieco P; Marabini A; Derenzini M
    Gynecol Oncol; 1994 May; 53(2):202-7. PubMed ID: 8188080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interphase AgNOR quantity is not related to DNA content in 11 established human cancer cell lines.
    Derenzini M; Trerè D; Chieco P; Melchiorri C
    Exp Cell Res; 1994 Apr; 211(2):282-5. PubMed ID: 8143774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo bromodeoxyuridine labelling index, AgNOR protein expression and DNA content in human tumours.
    Trerè D; Ceccarelli C; Danova M; Derenzini M
    Eur J Histochem; 1996; 40(1):17-26. PubMed ID: 8741096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of DNA ploidy pattern and nucleolar organizer regions (AgNOR) in colorectal carcinoma.
    Eminović-Behrem S; Trobonjaca Z; Petrovecki M; Dobi-Babić R; Dujmović M; Jonjić N
    Croat Med J; 2000 Jun; 41(2):154-8. PubMed ID: 10853043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
    Singh M; Prasad S; Kalra N; Singh U; Shukla Y
    Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic value of AgNORs in breast cancer].
    Aubele M; Auer G; Jütting U
    Zentralbl Pathol; 1994 Mar; 140(1):55-60. PubMed ID: 7515674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interphase nucleolar organizer regions in the evaluation of serosal cavity effusions.
    Carrillo R; Sneige N; el-Naggar AK
    Acta Cytol; 1994; 38(3):367-72. PubMed ID: 8191825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry.
    Borgiani L; Cogorno P; Oliviero J; Toso F; Gambini G; Tunesi G; Canepa M
    Eur J Histochem; 1994; 38(2):171-6. PubMed ID: 7524814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues.
    Takahashi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ploidy and kinetics: comparative study with DNA flow cytometry and AgNOR protein quantification with image analysis.
    Grigolato PG; Tebaldi P; Cadei M; Alpi F; Lucchini K
    Eur J Histochem; 1997; 41 Suppl 2():131-2. PubMed ID: 9859816
    [No Abstract]   [Full Text] [Related]  

  • 12. Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes?
    Giuffrè G; Barresi G; Speciale G; Sarnelli R; Gioffrè Florio MA; Tuccari G
    Eur J Histochem; 1997; 41(2):111-8. PubMed ID: 9271703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleolar organiser regions (AgNORs) related to histopathological characteristics and survival in prostatic adenocarcinoma.
    Eskelinen M; Lipponen P; Syrjänen K
    Anticancer Res; 1992; 12(5):1635-40. PubMed ID: 1444230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool.
    Giuffrè G; Mormandi F; Barresi V; Bordi C; Tuccari G; Barresi G
    Eur J Histochem; 2006; 50(1):45-50. PubMed ID: 16584984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of the AgNOR in tumor pathology].
    Pich A; Margaria E; Chiusa L
    Pathologica; 2002 Feb; 94(1):2-9. PubMed ID: 11912874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of DNA ploidy and proliferation rate in lung tumours by bromodeoxyuridine labelling index, S-phase fraction and AgNOR technique.
    Gasińska A; Biesaga B; Kołodziejski L; Słonina D
    Pol J Pathol; 1996; 47(4):201-7. PubMed ID: 9097713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleolar organizer regions: a potential prognostic factor in adenocarcinoma of the endometrium.
    Miller B; Morris M; Silva E
    Gynecol Oncol; 1994 Aug; 54(2):137-41. PubMed ID: 8063236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital image analysis of silver-stained nucleolar organizer region--associated proteins in endometrial cytologic samples.
    Mahovlić V; Audy-Jurković S; Ovanin-Rakić A; Bilusić M; Veldić M; Babić D; Bozikov J; Danilović Z
    Anal Quant Cytol Histol; 1999 Feb; 21(1):47-53. PubMed ID: 10068775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic model of survival in surgically resected squamous cell carcinoma of the lung using clinical, pathologic, and biologic markers.
    Bernardi FD; Antonângelo L; Beyruti R; Takagaki T; Saldiva PH; Capelozzi VL
    Mod Pathol; 1997 Oct; 10(10):992-1000. PubMed ID: 9346178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Silver-stained Nucleolar Organizer Regions (AgNOR)].
    Derenzini M; Trerè D
    Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.